Department of Endocrinology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
Int J Clin Pract. 2011 May;65(5):592-601. doi: 10.1111/j.1742-1241.2011.02653.x.
The objective was to examine the independent and gender-specific effects of WC and BMI on CVD risk factors, insulin resistance and β-cell function.
A cross-sectional study of 2931 adults aged 20-79 years was carried out in Fujian province by multi-stratified sampling from July 2007 to May 2008. Gender-specific differences of WC and BMI on CVD risk factors, insulin resistance and β-cell function were displayed jointly by WC and BMI tertiles. The homeostasis model assessment of insulin resistance (HOMA-IR) index and the quantitative insulin-sensitivity check index (QUICKI): l/(log G0 ± log I0) were used to estimate insulin sensitivity; insulin secretion was assessed using the HOMA-β index; β-cell function was quantified as the ratio of the incremental insulin to glucose responses over the first 30 min during the OGTT (△I30/△G30). The oral disposition index (DIo) was calculated as ΔI(30) /ΔG(30) × 1/fasting insulin. The Matsuda index is defined as 10,000/sqrt (FBG × FPI × [G × I]) where FPG is fasting glucose, FPI is fasting insulin, G is mean glucose during the OGTT (calculated from glucose samples at 0, 30, and 120 min), and I is mean insulin during the OGTT (calculated from insulin samples at 0, 30, and 120 min).
Waist circumference and BMI correlated with each other in both men (0.756, p < 0.001) and women (0.728, p < 0.001). The two indexes were independently associated with CVD risk factors (such as hypertension, metabolic syndrome, and dyslipidaemia) in both men and women. BMI was better than WC in assessing the risk of diabetes in men (p = 0.003 for BMI, and p = 0.234 for WC), while WC was better than BMI in predicting diabetes in women (p < 0.001 for WC, and p = 0.831 for BMI). There were significant associations between BMI and insulin resistance or β-cell function even after adjustment for WC except for DIo in male subjects, but WC only associated with HOMA-IR positively or the Matsuda index and QUICKI negatively after adjustment for BMI. For women, associations between WC and insulin resistance or β-cell function remained strong even after adjustment for BMI besides DIo. However, there were no independent relations of BMI to insulin resistance and β-cell function except for Matsuda index with a significant negative association after adjustment for WC in women.
Body mass index and WC were independently associated with CVD risk factors. There were differences in the gender-specific relevance of measures of body fat distribution in assessing the insulin resistance, β-cell function and thus the risk of diabetes. Therefore, WC should be measured in addition to BMI to assess CVD risk accurately and implement efficient treatment strategies.
研究腰围(WC)和体重指数(BMI)对心血管疾病(CVD)风险因素、胰岛素抵抗和β细胞功能的独立和性别特异性影响。
2007 年 7 月至 2008 年 5 月,采用多阶段分层抽样方法,在福建省对 2931 名 20-79 岁成年人进行了横断面研究。联合 WC 和 BMI 三分位数,共同显示 WC 和 BMI 对 CVD 风险因素、胰岛素抵抗和β细胞功能的性别特异性差异。稳态模型评估的胰岛素抵抗(HOMA-IR)指数和定量胰岛素敏感性检查指数(QUICKI):l/(log G0 ± log I0)用于估计胰岛素敏感性;使用 HOMA-β 指数评估胰岛素分泌;β细胞功能通过 OGTT 中前 30 分钟内胰岛素与葡萄糖反应的增量(△I30/△G30)来量化。口服处置指数(DIo)计算为△I(30)/△G(30)×1/空腹胰岛素。Matsuda 指数定义为 10000/√(FBG×FPI×[G×I]),其中 FPG 是空腹血糖,FPI 是空腹胰岛素,G 是 OGTT 期间的平均血糖(根据 0、30 和 120 分钟时的血糖样本计算),I 是 OGTT 期间的平均胰岛素(根据 0、30 和 120 分钟时的胰岛素样本计算)。
男性(0.756,p<0.001)和女性(0.728,p<0.001)中,腰围和 BMI 相互关联。这两个指标在男性和女性中均与 CVD 风险因素(如高血压、代谢综合征和血脂异常)独立相关。在男性中,BMI 比 WC 更能预测糖尿病的风险(BMI 为 p=0.003,WC 为 p=0.234),而 WC 比 BMI 更能预测女性糖尿病的风险(WC 为 p<0.001,BMI 为 p=0.831)。即使调整了 WC,BMI 与胰岛素抵抗或β细胞功能之间仍存在显著关联,但除了男性中的 DIo 外,WC 仅与 HOMA-IR 呈正相关,与 Matsuda 指数和 QUICKI 呈负相关。对于女性,即使调整了 BMI,WC 与胰岛素抵抗或β细胞功能之间的关联仍然很强,除了 DIo 外,BMI 与 Matsuda 指数呈显著负相关。
体重指数和 WC 与 CVD 风险因素独立相关。在评估胰岛素抵抗、β细胞功能和糖尿病风险方面,身体脂肪分布指标的性别特异性相关性存在差异。因此,除了 BMI 外,还应测量 WC 以准确评估 CVD 风险并实施有效的治疗策略。